Mar 31, 2026 | Data Analytics, New Technology
Artificial intelligence has become a fixture in pharmaceutical strategy conversations. Nearly every major organization has invested in it in some form, whether through internal teams, external partnerships, or acquisitions. The expectation is clear: AI should...
Feb 28, 2026 | Data Analytics, Industry Trends, Market Scan, New Technology
Examining the innovation-to-risk balance among the pharmaceutical industry’s top companies In our previous post, we evaluated the pharmaceutical industry’s leading companies in terms of overall R&D pipeline strength, resulting in Roche, AstraZeneca, Bristol-Myers...
Jan 16, 2026 | New Technology, Probability of Success
Unlocking Next-Gen POS Forecasting for Biopharma Success In the high-stakes world of biopharma, advanced Probability of Success (POS) forecasting can revolutionize the landscape of clinical trials. By adopting next-gen POS forecasting models, companies can...
Dec 16, 2025 | Market Scan
Introduction to GLP-1 Agonists GLP-1 agonists have been pivotal in the pharmaceutical market for nearly two decades, beginning with the FDA approval of AstraZeneca’s Byetta in 2005. Since then, the landscape has seen numerous entries and exits, leaving Novo Nordisk...
Nov 9, 2025 | New Technology, Probability of Success
Redefining Probability of Success in Pharma: A Data-Driven Revolution In the world of pharmaceutical strategic planning and analytics, traditional Probability of Success (POS) forecasts are a familiar, yet often frustrating approach to assessing clinical risk. While...
